Rachel LaCasse
- Molecular Biology top 10%
- Infectious Diseases top 2%
- Neurology top 2%
- Epidemiology top 10%
- Nutrition and Dietetics top 5%
- Co-authors
- Bruce ChesebroKimberly Meade‐WhiteRichard RaceCynthia FavaraHeinz FeldmannMatthew J. TrifiloMichael B. A. OldstoneFriederike Feldmann
- Topics
- Viral Infections and Outbreaks Research (7 papers)Viral Infections and Vectors (7 papers)HIV Research and Treatment (6 papers)
- Cited by
- NeurologyInfectious DiseasesVirology
- Journals
- ScienceNature MedicinePLoS ONE
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Rachel LaCasse
27 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 74
- Molecular Biology 868
- Infectious Diseases 715
- Neurology 460
- Epidemiology 327
- Nutrition and Dietetics 297
Countries citing papers authored by Rachel LaCasse
This map shows the geographic impact of Rachel LaCasse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel LaCasse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel LaCasse more than expected).
Fields of papers citing papers by Rachel LaCasse
This network shows the impact of papers produced by Rachel LaCasse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel LaCasse. The network helps show where Rachel LaCasse may publish in the future.
Co-authorship network of co-authors of Rachel LaCasse
This figure shows the co-authorship network connecting the top 25 collaborators of Rachel LaCasse. A scholar is included among the top collaborators of Rachel LaCasse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel LaCasse. Rachel LaCasse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 32 | |
| 3 | 172 | |
| 4 | 16 | |
| 5 | 21 | |
| 6 | 93 | |
| 7 | 44 | |
| 8 | 58 | |
| 9 | 81 | |
| 10 | 17 | |
| 11 | 17 | |
| 12 | 112 | |
| 13 | 19 | |
| 14 | 23 | |
| 15 | 5 | |
| 16 | Anchorless Prion Protein Results in Infectious Amyloid Disease Without Clinical Scrapiebreakdown → | 500 |
| 17 | 96 | |
| 18 | 10 | |
| 19 | 9 | |
| 20 | 20 |
About Rachel LaCasse
Rachel LaCasse is a scholar working on Virology, Infectious Diseases and Neurology, having authored 28 papers that have together received 1.7k indexed citations. Recurring topics across this work include Viral Infections and Outbreaks Research (7 papers), Viral Infections and Vectors (7 papers) and HIV Research and Treatment (6 papers). The work is most often cited by research in Neurology (460 citations), Infectious Diseases (715 citations) and Virology (174 citations). Rachel LaCasse has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Bruce Chesebro, Kimberly Meade‐White, Richard Race, Cynthia Favara, Heinz Feldmann, Matthew J. Trifilo, Michael B. A. Oldstone, Friederike Feldmann, Elaine Haddock and Lynne D. Raymond. Their work appears in journals such as Science, Nature Medicine and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.